Enteroshield Vaccine 0.5ml Injection

Enteroshield Vaccine 0.5ml Injection is a typhoid conjugate vaccine specifically formulated for active immunization against typhoid fever, a serious illness caused by the bacterium Salmonella typhi (S. Typhi). This vaccine contains 25mcg of Vi capsular polysaccharide from Salmonella typhi, which is chemically conjugated to a carrier protein to enhance the immune response. It is indicated for the prevention of typhoid fever in individuals aged 6 months and older.

Maintaining the integrity of the vaccine requires strict adherence to cold-chain storage conditions, with temperatures kept between 2°C and 8°C, and it must not be frozen. Enteroshield Vaccine is WHO Prequalified and IAP Approved, signifying its compliance with international quality and safety standards. The vaccine is manufactured by Abbott India Ltd..

The Enteroshield Vaccine 0.5ml Injection is administered by a healthcare professional as a single 0.5ml dose via intramuscular (IM) injection. For optimal protection, it is generally recommended to administer the vaccine at least 2 weeks prior to anticipated exposure. Booster doses may be considered approximately 3 years after the primary vaccination for high-risk individuals who continue to have exposure to Salmonella typhi.

Key Features : 

Antigen Composition: Vi Capsular Polysaccharide Of Salmonella Typhi 25mcg
Approved Indications: Active immunization for prevention of typhoid fever caused by Salmonella typhi (S. Typhi)
Cold-chain Storage: Requires storage between 2°C and 8°C; do not freeze
Regulatory Approval: WHO Prequalified and IAP Approved
Route of Administration: Intramuscular (IM) injection